Catalina

Excited to announce Aubrey Rankin’s appointment to Nanostics’ Board of Directors! Read more at nanosticsdx.com/media/ or bit.ly/3X2T9rg #ProstateCancer #ClarityDXProstate #diagnosis

Excited to announce receiving the CE Mark for its ClarityDX Prostate® test that uses machine-learning plus biological and clinical biomarker data to generate a risk score for clinically significant prostate cancer. prn.to/3dODeLb

We're excited to announce the launch of a clinical study to validate our bladder cancer diagnostic test and improve patient outcomes. Supported in part by @ABInnovates AICE-Concepts. bwnews.pr/3ISH41g #diagnostics @Bioalberta @HIH_YEG @HealthCities @UofAResearch @dynaLIFE

Interested in volunteering? Please contact IWK! Details in CBC news below. #COVID19 @GPAinsights @DalhousieU @UofAResearch cbc.ca/news/canada/no…

Some great work being done on the ground in #Halifax to support clinical trials for Canadian domestic #COVID19 vaccines! 🇨🇦💉

Entos’ COVID-19 vaccine Phase trial met 1st milestone-thank you Halifax! CCfV is now enrolling Halifax area adults to complete the trial. Interested? Learn more at bit.ly/trialvolunteer #COVID19Vaccines @Bioalberta @DalhousieU @VACCres @GPAinsights @UofAResearch

Catalina Vasquez and Colin Coros want to thank @jfedeyko Joanne Fedeyko at @connectsv for this excellent opportunity to meet and have discussions with Silicon Valley entrepreneurs, VC, and inspirational coaches. #CanadianLandingPad #startup #SiliconValley

Nanostics accepts the challenge! Our study Monitor/Data Manager, Aditya Muley, will be at this course too. Meet with Aditya to get your awesome UofA (size med) hoodie!

CSO Desmond Pink @pinknewfie is in Miami, Florida this week to give a talk on Nanostics' liquid biopsy, ClarityDX Prostate at AACR's Advances in Liquid Biopsies. Must See! DM Desmond to chat on #EVs #Extracellularvesicles #flowcytometry #AACRLB20

Add John Lewis' presentation on Nanostics and ClarityDX Prostate-highly accurate aggressive prostate cancer test- to your #JPM20 calendar! #biotechshowcase, Hilton Union Square, Monday, Jan 13, 4:45 pm. DM Catalina @catavasher or Colin @aminostrategies to meet! #diagnostics

We're in San Francisco for #JPM20! Entos develops next-gen nucleic acid-therapies with our proprietary delivery system: Fusogenix. DM CEO John Lewis @APCaRI_CA and CSO Arun Raturi @arunraturi to learn more! entospharma.com #biopharma #HealthTech #JPM2020

The men of @Nanostics R&D; Mike Wong, @renjithpillai78 and Desmond Pink @pinknewfie say, "Grow a Mo, save a Bro" and that's what they did. Go to nanosticsdx.com to find out about ClarityDX Prostate. #Movember #ProstateCancer

Going to the BIO Investor Forum company talks? CEO John Lewis is presenting on Oct 22. John and CCO Colin Coros look forward to chatting about our diagnostic platform and lead product ClarityDX Prostate. More at nanosticsdx.com/events #BIF19 #diagnostics #prostatecancer

We're expanding our @Nanostics ClarityDX Prostate clinical validation study into the US with a recruitment site at Century Clinical Research Inc., Daytona Beach, FL. Read more at bit.ly/Nanostics nanosticsdx.com #clinicaltrials #ProstateCancer

Great @AlbertaImpact “live” episode with our COO Catalina Vasquez @catavasher and CCO Colin Coros @aminostrategies! Watch to learn more about our Prostate Cancer diagnostic test. m.youtube.com/watch?v=LHQG2R…

ASEMV2019 Display table open for business!

We're at ASEMV2019 in Pacific Grove, CA and looking forward to meeting you at our CEO John Lewis' talk and our booth to chat about EVs, uFCM and diagnostics! nanosticsdx.com/events #extracellularvesicles #ASEMV2019

@entospharma is excited to announce a new partnership with a clinical-stage biopharma company to develop new therapeutics with our Fusogenix tech to target autoimmune and inflammatory diseases. bit.ly/Entos_2019 #pressreleases #immunotherapy #nextgeneration

Entos Pharmaceuticals announces research #EntosPharmaceuticals @EntosPharmaceuticals scienmag.com/entos-pharmace…

Congrats to #UAlberta spinoff Entos on partnership w/ clinical stage biopharma to develop new autoimmune & inflammatory disease therapeutics using Entos’ Fusogenix technology. #immunotherapy #ABbiz @TECEdmonton @WD_Canada @AlbertaEconomy @GiveToUHF @InnovateYEG